Immunoprecipitation Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2028

Technological advancements in immunoprecipitation techniques and increasing deployment in treatment of cancer and cardiovascular diseases expected to bolster market growth

Market Size – USD 621.96 million in 2020, Market Growth – at a CAGR of 5.2%, Market Trends – Scientific developments in genetic and biological therapies

The global immunoprecipitation market size is expected to reach USD 922.26 Million by 2028 and register a CAGR of 5.2% over the forecast period, according to the latest report by Reports and Data. Increasing research programs in pharmaceutical and biotechnology industries, rise in R&D collaborations between academic institutes and pharmaceutical companies, and technological advancements in immunoprecipitation techniques are among some of the key factors fueling market revenue growth. Rising need for identifying antigens related to autoimmune diseases, surge in research activities in the areas of immunotherapy, genomics, drug development, and personalized medicine, and increased investments in biopharmaceutical research & development activities are other factors supporting global market growth. Rising demand for advanced immunoprecipitation testing to treat cancer, cardiovascular diseases, and central nervous disorders is another major factor expected to fuel global immunoprecipitation market growth going ahead.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4000  

Immunoprecipitation (IP) refers to the technique that involves precipitation of a protein antigen using an antibody that binds to that particular protein. The process involves immobilization of a specific antibody to a solid support such as agarose resin or magnetic particles to purify the antigens. Immunoprecipitation is extensively used to isolate the target protein antigen and determine its structure, expression, and modification state. Co-immunoprecipitation (Co-IP), individual protein immunoprecipitation, Chromatin immunoprecipitation (ChIP), and RNA Immunoprecipitation (RIP) are the most widely used immunoprecipitation types. ChIP assays are used to identify DNA-binding proteins’ genomic regions, while RNA immunoprecipitation identifies RNA-binding proteins using techniques such as cDNA and RT-PCR sequencing.

Some of the players profiled in the report are

Thermo Fisher Scientific, Abbkine Scientific Co. Ltd., Merck KGaA, Bio-Rad Laboratories, BioLegend, Cell Signaling Technology, Abcam, GenScript Biotech Corporation, Rockland Immunochemicals, Geno Technology, and Takara Bio.

Some Key Highlights From the Report:

·         Based on product type, the reagents segment accounted for largest revenue share in the global immunoprecipitation market in 2020. Increasing use of antibodies, buffers, and beads for immunoprecipitation procedures, escalating demand for advanced IP assays for antigen isolation and purification, and increasing usage of agarose and magnetic beads in protein purification are some of the key factors expected to continue to drive revenue growth of this segment.

·         Academic & research institutes segment accounted for substantially large revenue share in 2020, and this trend is expected to continue over the forecast period. Robust growth of this segment is attributed to increasing research and development activities in the fields of molecular biology and genomics, growing research collaborations among global academic institutions, and considerable government investments in academic R&D programs.

·         North America market accounted for largest revenue share in 2020, owing to surging government investments in R&D activities in the life sciences industry, increasing research collaborations between pharmaceutical companies and academic institutions, and rising number of COVID-19 infections and deaths in countries in the region. The Asia Pacific immunoprecipitation market is expected to register highest revenue CAGR over the forecast period. Steady growth of the market in the region is attributed to increased government investments in pharmaceutical and biotechnological R&D activities, rising adoption of personalized medicine, and availability of state-of-the-art healthcare infrastructure in the region.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4000

By Type (Revenue, USD Million; 2018-2028)

• Individual protein immunoprecipitation
• Chromatin Immunoprecipitation (ChIP)
• Co-immunoprecipitation (Co-IP)
• RNA Immunoprecipitation (RIP)
• Others

By Product Type (Revenue, USD Million; 2018-2028)

• Kits
• Accessories
• Reagents

• Antibodies
• Primary Antibodies
• Secondary Antibodies
• Beads
• Agarose Beads
• Magnetic Beads
• Buffers

By End-use (Revenue, USD Million; 2018-2028)

• Pharmaceutical and Biopharmaceutical Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)
• Others

Market Segmentation by Regions:

• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To know more about the report @ https://www.reportsanddata.com/report-detail/immunoprecipitation-market

Key Points Covered in the Report:

• Key insights into the latest growth trends, developments, technological and product advancements, and research and development scenario
• Analysis of micro- and macro-economic factors and regulatory framework
• In-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends
• SWOT analysis, Porter’s Five Forces Analysis, investment return analysis, and feasibility analysis to offer a comprehensive view of the competitive landscape
• Strategic recommendations to established market players and new entrants to overcome limitations and entry-level barriers in the global market landscape
• Analysis of market drivers, restraints, challenges, limitations, threats, growth prospects and opportunities

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/4000

Thank you for reading the report. The report can be customize as per requirements of the clients. For further information or query about customization, please reach out to us and we will offer you the report best suited for your needs.